Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvoxamine in pediatric depression
NCT00353028Phase 4Completed
- Sponsor
- Solvay
- Start
- Oct 2006
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluvoxamine in major depressive disorder (MDD), sponsored by Solvay. Started Oct 2006; status: completed.
02
Drugs
fluvoxamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00353028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00353028.